Skip to main content

Radiopharmaceuticals For Radionuclide Therapy

Tracking # 20-1348555

$30.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

This tutorial is related to Radiopharmaceuticals for Radionuclide Therapy and gives an overview of its role in Nuclear Medicine. After completing the review of this tutorial, one should be able to 1.List the most important characteristics of the ideal therapeutic radiopharmaceutical 2.Discuss each of these as it relates to current practice in Radionuclide Therapy. 3.Discuss the various thyroid diseases that are treatable with radioiodide 4.Know the activities administered for each condition and the radiation dose delivered to the patient 5.Describe P-32 therapy for patients with Polycythemia Vera or malignant effusions, and should be able to identify the appropriate radiopharmaceutical for each of these diseases. 6.Describe the procedure, radiation dosimetry, and projected outcome in patients treated with Sr-89 chloride and similar radiopharmaceuticals for palliation of bone pain secondary to metastases 7.Describe the treatment of intractable rheumatoid arthritis using radiation synovectomy with radiolabeled ferric hydroxide macroaggregates.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Nuclear Pharmacist

2h In-Depth Treatment of Nuclear Pharmacist Practice

Pharmacist

2h General

Disclosure statements

nothing to disclose